RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O https://t.co/d4ZSflKIyK
RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O
RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O https://t.co/d4ZSflKIyK
RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O
RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O
@johannLpunkt @SHomburg @Karl_Lauterbach Vielleicht wäre es aber besser auch jene zu lesen die tatsächlich solche Studien machen und nicht nur Interpretationen: https://t.co/LxdZNLTaqm
RT @JezChuWeg: @sburke85 @AlexBerenson @HighWireTalk Here is the study that found 40-60% cross-immunity, published in mid-May. https://t.c…
RT @kenmomd: インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O
@GeriMonsen1 @fun_magnets @davidmweissman @realDonaldTrump @MLevitt_NP2013 Not much time to have a pile of peer-reviewed studies on the exact seroprevalence required. However, more and more like this are coming out. Original pre-print then peer-reviewed D
@sburke85 @AlexBerenson @HighWireTalk Here is the study that found 40-60% cross-immunity, published in mid-May. https://t.co/zyCUPZA9DN
インフル関係 対インフルエンザにも交差反応性T細胞は存在し、重症化を軽減させている可能性 https://t.co/U6rweMAa3O
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
RT @jorgegomezmarin: No temais, tus células están alli: https://t.co/Ah9fGybnf5 https://t.co/dvByCDueS8
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
@KonProg Auch Drosten hat ja schon mal erwähnt, dass es Kreuzimmunität geben *könnte* (Betonung auf Könnte). Und andere hatten diese theoretische Möglichkeit auch schon in Papers aufgeworfen. Dann aber schnell klargestellt: https://t.co/LxdZNLBz1M
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
@MackayIM The preprint of the Crotty and Sette study was out a little earlier, May 14... https://t.co/4DOHloFQYt Bertoletti preprint was also around then May 27... https://t.co/OYazJppTLO Both are now fully published.
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
RT @profshanecrotty: Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://…
Someone sent me this gif of Tony Fauci holding up our COVID-19 Cell paper in Congress. Think of all the uses! https://t.co/7s3m82sB2U @SetteLab @CellCellPress @ljiresearch https://t.co/jF6qe814fY
RT @gerdosi: “we detected SARS-CoV-2−reactive CD4+ T cells in ∼40-60% of unexposed individuals, suggesting cross-reactive T cell recognitio…
@ThumbarseHuber @Raf_Epstein Here you go. There are others, but do your own research. https://t.co/ANCJli9w9n
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @PishPishCat: @venivici27 @FatEmperor @daniellevitt22 @MLevitt_NP2013 @AlistairHaimes You may be interested in those as well. Numbers lo…
RT @PishPishCat: @venivici27 @FatEmperor @daniellevitt22 @MLevitt_NP2013 @AlistairHaimes You may be interested in those as well. Numbers lo…
RT @PishPishCat: @venivici27 @FatEmperor @daniellevitt22 @MLevitt_NP2013 @AlistairHaimes You may be interested in those as well. Numbers lo…
https://t.co/Wkcmmnh3Lm カロリンスカ大学: 重要なのは2015年から2018年に採取された健常な20例では、約40%〜60%でSARS-CoV-2反応性CD4 + T細胞が検出された。 「一般的な風邪」の4つのコロナウイルス(OC43、HKU1、NL63、229E)とSARS-CoV-2の交差反応性T細胞が存在すると考えられた。
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals - PubMed https://t.co/rpJXYjm7eP
@DogGunn @Raf_Epstein "Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2. https://t.co/eFCQoW9Qac
RT @PishPishCat: @venivici27 @FatEmperor @daniellevitt22 @MLevitt_NP2013 @AlistairHaimes You may be interested in those as well. Numbers lo…
@venivici27 @FatEmperor @daniellevitt22 @MLevitt_NP2013 @AlistairHaimes You may be interested in those as well. Numbers lower than 81%, but still encouraging and same conclusion. 30%: https://t.co/AvzVAzVZVt 50%: https://t.co/ISgRwaC1xt 34%: https://t.c
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @pbleic: 40-60% of people have T cells reactive to SC2. Since coronaviruses make up ~20% of common colds, could the remainder never hav…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @pbleic: 40-60% of people have T cells reactive to SC2. Since coronaviruses make up ~20% of common colds, could the remainder never hav…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
RT @kenmomd: インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 dise…
インフルエンザと交差反応性T細胞の関係 https://t.co/IANRWJNIq4 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals https://t.co/ZZ4YfXSfFR https://t.co/HKQR4wnZsX
Technical stuff for us lay people. But an interesting study on those who may seem protected against the disease but surprisingly have not encountered said disease. The (scientific) beauty of using blood samples collected years before Covid19 appeared. h
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
@DFisman what do you make of this study? Is it plausible we have T cells that may protect some people from getting more sick than others? Could that also explain why some countries have had less severe cases? https://t.co/gkAiweCd4N
RT @pbleic: 40-60% of people have T cells reactive to SC2. Since coronaviruses make up ~20% of common colds, could the remainder never hav…
RT @pbleic: 40-60% of people have T cells reactive to SC2. Since coronaviruses make up ~20% of common colds, could the remainder never hav…
Recent research sheds light onto why some may have immunity to the novel coronavirus. If it pans out the implication is that we'd need to vaccinate a much smaller portion of the population to get to herd immunity. https://t.co/NzOC5SQlQo #covid #covidcure
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
40-60% of people have T cells reactive to SC2. Since coronaviruses make up ~20% of common colds, could the remainder never have had a coronavirus cold? Are they the most susceptible to severe illness? Need pre-COVID cells from them to know. https://t.c
la llamada inmunidad humoral, Resultó que algunas células T ya saben cómo responder al SARS-CoV-2. Por eso algunas personas toleran más fácilmente el COVID-19 o son asintomáticas totalmente. https://t.co/s8xhPlGiwX
@CovidSerology @florian_krammer @g17891 @NahasNewman @VirusesImmunity I'm confused now, because I read this doc…and it certainly seems to indicate that there IS some sort of natural existing communal immunity from previous coronaviruses, everyone in the th
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @gerdosi: “we detected SARS-CoV-2−reactive CD4+ T cells in ∼40-60% of unexposed individuals, suggesting cross-reactive T cell recognitio…
RT @gerdosi: “we detected SARS-CoV-2−reactive CD4+ T cells in ∼40-60% of unexposed individuals, suggesting cross-reactive T cell recognitio…
Would you lock down if 50% of the population were immune without ever being exposed to SARS-CoV-2? https://t.co/ldCabbGV6b #COVID19
RT @MenePangalos: Great paper for anyone interested in the immune response to SARS-CoV2- highlights the importance of not just neut antibod…
@JackGreenJ2 @Peppers00581730 @S__KETC @ProfKarolSikora Some data: https://t.co/nCq4GBLxXJ There's lots of papers out there. More are being published every day
@mjthisisforyou @VariusStrato @BenjaLuxen @alferdez Es muy contagioso pero la mortalidad se estima del 0,2% y yo creo que es algún mejor porque hay varios tests serologicos que tienen falsos negativos. El 50% de la gente es inmune sin haber estado expuesto
@juancinavarrete @rafam1234 @CapLiberal Estimados hoy en día se sabe mucho del COVid-19 incluyendo varios estudios dónde ven q el 50% tiene immunidad como si se hubiesen vacunados sin haber estado expuesto previamente, xq su estructura es parecida a otros
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @picphysicians: Did you know exposure to coronaviruses that cause the common cold appear to allow your immune system to recognize and fi…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
RT @nodasori2525: 既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差…
既存の風邪コロナウイルスの免疫記憶が新型コロナと交差反応したという研究結果。新型コロナ出現前(2015-2018年)に採取されたアメリカ人の血液20例に、新型コロナ肺炎から回復した患者の血液をかけあわせたら、約半数が免疫反応。これが死亡率の差の原因か。 https://t.co/hNpGz7lqzX
@mclagerbreath @formconspiracy @MclernonDylan @az_reason @miltimore79 Re: "100% people" Unsourced claim of you're noted. Make sure not to pretend that cross-reactivity entails a benefit, given your lack of background in immunology. https://t.co/3qevbUWT
@12FreeBeer @ljiresearch Re: "Click on the link:" Already did, troll. The title of the paper doesn't say what u claimed, because u don't know what "cross-reactivity" is. You never read it. https://t.co/ImHxIqsG8S https://t.co/lnGCBWy9d1
@12FreeBeer @ljiresearch You never read the study, and i already told u what the study's author said: https://t.co/iLpE7GTwEr
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @A__Aicha: @MF_NephroEpi @SidySissokho Papier #1: https://t.co/39je5ukeyw Papier #2: https://t.co/5A725dJdn5 Et même, les résultats de…
@MF_NephroEpi @SidySissokho Papier #1: https://t.co/39je5ukeyw Papier #2: https://t.co/5A725dJdn5 Et même, les résultats de l'étude clinique du vaccin en phase 2: https://t.co/5mYzWMXQM8 2/ https://t.co/RJhiv7YCp1
@jmvinie Hermano, salieron varios estudios en las revistas más prestigiosas del mundo, Nature y cell Al respecto. Me sorprende tu soberbia en un tema que no manejas. Yo no hablo con tanta confianza en historia que no es mí tema. https://t.co/UgBCGawmCR htt
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
@12FreeBeer They fundamentally do not grasp that having an immune response does not entail that said response is beneficial. https://t.co/Nr0ZcThD36 https://t.co/iLpE7GBVMT
@spittingkitty @GregMcAndrews35 @GovMurphy @CranfordBasebal @NJLastdance There are many epidemiologist who will argue HI is obtained at much lower numbers and without a vaccine, yes vaccine can help, but it may not be necessary depending upon the iCFR ht
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…
RT @MenePangalos: Great paper for anyone interested in the immune response to SARS-CoV2- highlights the importance of not just neut antibod…
@12FreeBeer @JerrBearr @NahasNewman @jerrbear Now that your one main trick has been exposed (pretending a cross-reactive immune response entails a beneficial response), u just seem to be flailing. As an immunologist, I'm not impressed by random claims not
RT @profshanecrotty: Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multi…